Liaoning He Eye Hospital Group Co., LTD. (SHE:301103)
China · Delayed Price · Currency is CNY 15.67
-0.26 (-1.63%)
Oct 29, 2026, 4:00 PM EDT
SHE:301103 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 2,434 | 3,047 | 3,125 | 4,738 | 4,981 | - | |
Market Cap Growth | -27.08% | -2.48% | -34.04% | -4.89% | - | - |
Enterprise Value | 1,193 | 1,861 | 1,904 | 3,291 | 3,318 | - |
Last Close Price | 15.67 | 19.45 | 19.80 | 28.65 | 29.43 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 90.99 | 111.47 | - | 74.55 | 152.83 | - |
Forward PE | - | 39.67 | 39.67 | 39.97 | - | - |
PS Ratio | 2.17 | 2.79 | 2.85 | 4.00 | 5.21 | - |
PB Ratio | 1.26 | 1.62 | 1.66 | 2.29 | 2.29 | - |
P/TBV Ratio | 1.28 | 1.65 | 1.69 | 2.32 | 2.33 | - |
P/FCF Ratio | 18.34 | 24.74 | 79.48 | - | 50.38 | - |
P/OCF Ratio | 15.01 | 19.42 | 20.08 | 26.80 | 33.66 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 1.06 | 1.70 | 1.74 | 2.78 | 3.47 | - |
EV/EBITDA Ratio | 8.41 | 19.12 | 37.30 | 24.62 | 30.23 | - |
EV/EBIT Ratio | 25.99 | 39.61 | - | 40.34 | 57.16 | - |
EV/FCF Ratio | 8.99 | 15.10 | 48.43 | - | 33.56 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.09 | 0.09 | 0.12 | 0.13 | 0.13 | 0.22 |
Debt / EBITDA Ratio | 1.15 | 1.15 | 2.08 | 1.35 | 1.75 | 1.02 |
Debt / FCF Ratio | 1.23 | 1.36 | 5.61 | - | 2.89 | 1.64 |
Net Debt / Equity Ratio | -0.64 | -0.62 | -0.56 | -0.64 | -0.71 | -0.44 |
Net Debt / EBITDA Ratio | -13.56 | -12.01 | -20.54 | -9.95 | -14.16 | -2.59 |
Net Debt / FCF Ratio | -9.35 | -9.49 | -26.66 | 113.26 | -15.72 | -3.27 |
Asset Turnover | 0.50 | 0.50 | 0.47 | 0.47 | 0.47 | 0.76 |
Inventory Turnover | 8.20 | 8.70 | 8.41 | 8.16 | 7.50 | 8.02 |
Quick Ratio | 7.83 | 8.42 | 7.76 | 8.26 | 11.26 | 4.56 |
Current Ratio | 8.35 | 8.99 | 8.31 | 8.94 | 11.88 | 5.15 |
Return on Equity (ROE) | 1.38% | 1.40% | -1.79% | 2.72% | 1.99% | 8.58% |
Return on Assets (ROA) | 1.27% | 1.33% | -0.15% | 2.00% | 1.80% | 6.45% |
Return on Invested Capital (ROIC) | 3.17% | 2.86% | 15.31% | 6.55% | 4.32% | 17.68% |
Return on Capital Employed (ROCE) | 2.20% | 2.30% | -0.30% | 3.60% | 2.40% | 10.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 1.10% | 0.90% | -0.88% | 1.34% | 0.65% | - |
FCF Yield | 5.45% | 4.04% | 1.26% | -0.25% | 1.98% | - |
Dividend Yield | 0.96% | 0.77% | 0.75% | 1.98% | 3.17% | - |
Payout Ratio | 86.73% | 85.22% | - | 248.66% | 223.78% | - |
Buyback Yield / Dilution | 1.92% | -0.01% | 0.00% | -6.71% | -25.10% | -0.00% |
Total Shareholder Return | 2.87% | 0.76% | 0.75% | -4.72% | -21.93% | -0.00% |